Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Orkla (ORK.OL)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (NKr)	Price Target (NKr)	Rating
2022-03-30	78.74	76.00	Sell
2022-04-05	80.46	73.00	Sell
2022-05-10	75.12	72.00	Sell
2022-07-21	81.18	77.00	Sell
2022-10-14	76.12	68.00	Sell
2022-11-07	68.24	64.00	Sell
2023-01-13	73.10	65.00	Sell
2023-02-21	69.26	62.00	Sell
2023-07-12	76.94	67.00	Sell
2023-10-10	79.72	73.00	Sell
2024-02-06	81.90	90.00	Neutral
2024-02-18	75.00	83.00	Neutral
2024-06-13	89.65	88.00	Neutral
2024-07-17	89.40	90.00	Neutral
2024-11-05	102.00	101.00	Neutral
2025-02-25	107.60	108.00	Neutral

Disclosures

UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.